Aim immunotech to discuss first quarter 2023 financial results on may 16, 2023 and host conference call and webcast

Ocala, fla., may 09, 2023 (globe newswire) -- aim immunotech inc. (nyse american: aim) (“aim” or the “company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including covid-19, the disease caused by the sars-cov-2 virus — announced today that management will host a conference call and webcast to discuss the company's q1 2023 operational and financial results on tuesday, may 16, 2023 at 8:30 am et.
AIM Ratings Summary
AIM Quant Ranking